Roche (OTCMKTS:RHHBY) Shares Gap Up - Should You Buy?

Key Points

• Roche Holding AG's stock price **gapped up** from $41.81 to **$43.71**, closing at **$44.00** on Wednesday, indicating a significant move in the market.
• Institutional investors have shown increased interest in Roche, with **GAMMA Investing LLC** boosting its stake by **6,463.8%** during the recent quarter.
• The company's **debt-to-equity ratio** stands at **0.85**, reflecting a stable financial structure relative to its equity, while its 50-day moving average is **$40.54**.

Roche Holding AG (OTCMKTS:RHHBY - )'s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $41.81, but opened at $43.71. Roche shares last traded at $44.00, with a volume of 158,855 shares traded.

Roche Trading Up 5.9%

The company's 50 day moving average price is $40.54 and its two-hundred day moving average price is $40.23. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.48 and a quick ratio of 1.20.

Institutional Investors Weigh In On Roche

Several hedge funds and other institutional investors have recently bought and sold shares of RHHBY. GAMMA Investing LLC increased its position in Roche by 6,463.8% during the first quarter. GAMMA Investing LLC now owns 528,778 shares of the company's stock worth $21,759,000 after purchasing an additional 520,722 shares during the last quarter. Boston Common Asset Management LLC increased its position in shares of Roche by 11.1% during the second quarter. Boston Common Asset Management LLC now owns 361,833 shares of the company's stock valued at $14,682,000 after acquiring an additional 36,101 shares during the last quarter. Bard Financial Services Inc. increased its position in shares of Roche by 25.3% during the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock valued at $5,716,000 after acquiring an additional 28,050 shares during the last quarter. Corient IA LLC acquired a new stake in shares of Roche during the first quarter valued at about $616,000. Finally, Moloney Securities Asset Management LLC increased its position in shares of Roche by 53.8% during the first quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company's stock valued at $1,672,000 after acquiring an additional 14,245 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.